iSpecimen Inc. Announces Adjournment and Rescheduling of 2025 Annual Meeting of Stockholders

Key Points from the 8-K Filing

• iSpecimen Inc. (NASDAQ: ISPC) filed a Form 8-K Current Report with the SEC dated April 13, 2026.
• The 2025 Annual Meeting of Stockholders, originally convened on December 31, 2025, was adjourned due to lack of quorum.
• The company intends to reconvene the Annual Meeting on May 8, 2026 at 9:00 a.m. Eastern Time.
• The record date for voting remains November 3, 2025. Only stockholders of record as of this date are eligible to vote at the reconvened meeting.
• No changes have been made to the proposals to be voted on at the Annual Meeting, which are described in the previously distributed Proxy Statement.
• The filing was signed by Katharyn Field, Chief Executive Officer of iSpecimen Inc.

Shareholder-Relevant and Potentially Price Sensitive Information

• Adjournment Due to Lack of Quorum: The inability to secure a quorum for the Annual Meeting may indicate low shareholder engagement. This can be viewed as a corporate governance concern, especially if critical matters are pending approval.
• Rescheduled Meeting Date: The reconvened meeting is set for May 8, 2026. Shareholders should be aware that the company emphasizes no changes to meeting proposals, suggesting that previously announced agenda items, including potential director elections, governance items, or other proposals, remain unchanged.
• Voting Record Date: There is no change in the record date (November 3, 2025), which means only those holding shares as of that date can participate in voting. Investors who have acquired shares after this date will not be eligible to vote at the reconvened meeting.
• Potential Share Price Impact: While the adjournment itself is not typically price moving, the underlying reasons—such as lack of engagement or uncertainty about key proposals—could be seen as negative by the market, especially if these issues persist or signal dissatisfaction among the shareholder base.

Other Details from the Filing

• Company Information:
  Name: iSpecimen Inc.
  Address: 8 Cabot Road, Suite 1800, Woburn, MA 08101
  Trading Symbol: ISPC
  Exchange: Nasdaq Stock Market LLC
  Entity Status: Emerging Growth Company
• SEC Compliance: The filing confirms that the company is not using the 8-K for written communications under Rule 425, soliciting material under Rule 14a-12, or pre-commencement tender offer communications under Rules 14d-2(b) or 13e-4(c).
• Filing Details: This 8-K does not amend any previous filing (“Amendment Flag: false”).

Conclusion

The adjournment and rescheduling of iSpecimen’s 2025 Annual Meeting of Stockholders due to lack of quorum is the key development disclosed in this 8-K. While no proposal changes are announced, shareholders and investors should pay close attention to the reconvened meeting on May 8, 2026, as the outcome may have implications for corporate governance and future strategic decisions. Lack of shareholder engagement and potential governance concerns could affect market sentiment and, in some cases, the company’s share price.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors are encouraged to read the full SEC filings and consult with a financial advisor before making investment decisions. The author and publisher are not responsible for any actions taken based on this summary.

View iSpecimen Inc. Historical chart here